KaydedilenlerDerginizi ekleyin

Dergiler / Üroonkoloji Bülteni / 2021 / Cilt: 20 - Sayı: 1

The Factors Affecting Recurrence and Prognosis in Patients with Low-grade Stage Ta Bladder Cancer

Mehmet Necmettin Mercimek
Mustafa Latif Özbek
Murat Gülşen
Yakup Bostancı
Şaban Sarıkaya
Fatih Kocamanoğlu
Mehmet Özen
Süleyman Öner
Sayfa
40–44
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Prevention of smoking and routine cystoscopic examination are essential in bladder cancer.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: This study aims to review the parameters affecting tumour recurrence, tumour progression and cancer survival of patients with low-grade non-muscle invasive bladder cancer.
📊
Temel Bulgular & Veri:Materials and Methods: We retrospectively reviewed 262 patients with primary, low-grade Ta bladder cancer.
💡
Sonuç & Katkı:Prevention of smoking and routine cystoscopic examination are essential in bladder cancer.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: This study aims to review the parameters affecting tumour recurrence, tumour progression and cancer survival of patients with low-grade non-muscle invasive bladder cancer. Materials and Methods: We retrospectively reviewed 262 patients with primary, low-grade Ta bladder cancer. Recurrence was defined as the occurrence of a new tumour in the prostatic urethra or bladder. Tumour progression was defined as confirmed high-grade Ta, all T1 or carcinoma in situ, upper tract recurrence or progression to T2. The associations between factors that affect recurrence and progression were analysed. Results: Tumour recurrence and progression occurred in 119 (45.4%) and 25 (9.5%) patients during follow-up (median follow-up: 50.9±36.3 months), respectively. Univariate and multivariate analyses demonstrate that smoking, multiple tumours and large tumours (3 cm3 cm) and smoking were risk factors for recurrence and progression. Prevention of smoking and routine cystoscopic examination are essential in bladder cancer.

🔖

Bu Makaleye Atıf Yap

Mercimek, M. N., Özbek, M. L., Gülşen, M., Bostancı, Y., Sarıkaya, Ş., Kocamanoğlu, F., Özen, M., Öner, S. (2022). The Factors Affecting Recurrence and Prognosis in Patients with Low-grade Stage Ta Bladder Cancer. Üroonkoloji Bülteni, Cilt: 20 - Sayı: 1, 40–44. https://ajindex.com/articles/645740

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Soukup V, Capoun O, Cohen D, et al. Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review. Eur Urol 2017;72:801-813
  2. Babjuk M, Burger M, Comperat EM, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. Eur Urol 2019;76:639-657
  3. Sylvester RJ, van der Meijden A, Witjes JA, et al. High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder. Urology 2005;66(6 Suppl 1):90-107
  4. Golabesk T, Palou J, Rodriguez O, et al. Long-term Bladder and Upper Urinary Tract Follow-up Recurrence and Progression Rates of G1-2 Non-muscle-invasive Urothelial Carcinoma of the Bladder. Urology 2017;100:145-150
  5. Rieken M, Xylinas E, Kluth L, et al. Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder. Eur Urol 2014;65:201-209
  6. Herr HW. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J Urol 2000;163:60-61; discussion 61-62
  7. Kobayashi H, Kikuchi E, Mikami S, et al. Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression. BMC Urol 2014;14:5
  8. Matsumoto K, Kikuchi E, Horiguchi Y, et al. Late recurrence and progression in non-muscle-invasive bladder cancers after 5-year tumorfree periods. Urology 2010;75:1385-139 0
  9. Han DS, Lynch KE, Chang JW, et al. Overuse of Cystoscopic Surveillance Among Patients With Low-risk Non-Muscle-invasive Bladder Cancer - A National Study of Patient, Provider, and Facility Factors. Urology 2019;131:112-119
  10. Nerli RB, Ghagane SC, Shankar K, et al. Low-Grade, Multiple, Ta Nonmuscle- Invasive Bladder Tumors: Tumor Recurrence and Worsening Progression. Indian J Surg Oncol 2018;9:157-161
  11. Zieger K, Wolf H, Olsen PR, Hojgaard K. Long-term follow-up of noninvasive bladder tumours (stage Ta): recurrence and progression. BJU Int 2000;85:824-828
  12. Prout GR Jr, Barton BA, Griffin PP, Friedell GH. Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group. J Urol 1992;148:1413-1419
  13. Akagashi K, Tanda H, Kato S, et al. Recurrence pattern for superficial bladder cancer. Int J Urol 2006;13:686-691 14.